Intellectual Property

Brazil-based law firm with a leading IP and life-sciences practice, contributing legal and regulatory analysis on psychedelic medicines in Brazil and advising on IP-protection strategy in regulated sectors.

UK law firm with a dedicated psychoactive medicines practice providing regulatory, commercial, and IP counsel for psychedelic and cannabis organizations across research, clinic, and supply-chain contexts.

Nonprofit psychedelic prior-art and patent-analysis organization that supports patent quality, prior-art discovery, and intellectual-property transparency for innovators, examiners, and the public.